Clinical Trials Logo

Clinical Trial Summary

The goal of this application is to test whether menthol and fruit flavors impact e-cigarette use through dissociable mechanisms and exert their effects differentially across nicotine doses.


Clinical Trial Description

This study examines the impact of menthol and fruit flavors on self-administration of e-cigarette solutions containing varying amounts of nicotine. This is a randomized, double-blind study with a within-subject cross-over design, using e-liquids with 5 different flavors and 4 different levels of nicotine for a total of 20 different e-liquid formulations. Each subject will participate in 4 test sessions. The order of flavor and nicotine delivery will be randomized. At each test session, they will undergo directed self-administration, in a randomized order, then an ad libitum self-administration session where they can choose among all of the e-cigarettes used during the directed session. The primary aims assess the impacts of nicotine and flavor (and their interactions) on participants' subjective ratings of the e-liquids during the 'directed' self-administration component, and self-administered puffs during the ad libitum self-administration component. In addition, the study will explore the impact of sex/gender and sensitivity to nicotine aversiveness or bitterness (as operationalized by genetic variations in the alpha-5 subunit of nicotinic acetylcholine receptor that influences the aversive effects of nicotine, or a taste receptor number 38 ( TAS2R38) important for bitterness perception) on study outcomes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04038515
Study type Interventional
Source Yale University
Contact
Status Enrolling by invitation
Phase Phase 2
Start date October 27, 2022
Completion date May 31, 2024

See also
  Status Clinical Trial Phase
Terminated NCT03576768 - QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt N/A
Completed NCT04124432 - Behavioral Pharmacology of Cannabis and Nicotine Phase 1
Completed NCT01223404 - Nicotinic Modulation of the Default Network N/A
Recruiting NCT05864586 - Developing E-liquid Product Standards (Sweet Spot Study) N/A
Completed NCT01227343 - Nicotine and Brain Imaging Research Study
Completed NCT05317195 - Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy Smokers N/A
Withdrawn NCT03010995 - The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study Phase 1
Active, not recruiting NCT04189146 - Inner Engineering Yoga Program on Short and Long Term Health Effects (ISHA-Impact): A Longitudinal Study N/A
Completed NCT05487456 - Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence N/A
Completed NCT03102931 - Switching to Low Oxidant Content Cigarettes in Adult Smokers N/A
Completed NCT03134339 - The Effect of Nicotine Delivery Rate on Reinforcement Early Phase 1
Recruiting NCT06346353 - Substance Consumption, Personality, and Cognitive Functioning of Chess Players
Completed NCT05383508 - Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes N/A